01/20/2014 | Mark Hillen
The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) issues a safety alert for Cosopt preservative-free single-dose eye drops
Americans love their cars and in many places you’re virtually stranded if you don’t drive. So does vision loss stop elderly Americans from driving?
Transplanting pancreatic Islets of Langerhans into the ocular anterior chamber of the eye allows researchers to effectively monitor ?-cell function.
The pupil of the eye is dark, and the cornea highly reflective – it acts as a mirror. Combine this with high resolution photography, and you get a whole new vista.
While other pharmaceutical companies are buying into ophthalmology, Pfizer is heading for the hills
The media have been building up “eyeball jewelry” as a potential craze, but the evidence suggests otherwise
Gene therapy for ocular disease will soon be available. Stem cell therapies too. They may be able to cure the currently untreatable, but at what price? And will anyone pay it?
12/03/2013 | Irv Arons, Mark Hillen
Therapies based on stem cell treatments are considered to have tremendous potential in medicine.
12/02/2013 | Mark Hillen
If you had VMT or MH and could avoid vitrectomy, you would. Might ocriplasmin let you?
Bayer and Regeneron have presented the phase III trial data for aflibercept treatment of myopic choroidal neovascularization
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
Access All Areas: Recognizing Global Education Impact 2024
POAG Preferences
The Future-Ready Surgeon
The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: